Quick answer
Body weight excluding fat — primarily skeletal muscle, organs, bone, and water. Preserving lean mass during GLP-1-driven weight loss is a focus of resistance training and protein intake recommendations.
Full definition
Lean body mass (LBM) is total body mass minus adipose tissue, encompassing skeletal muscle, organs, bones, blood, and lymphatic tissue. Skeletal muscle alone is sometimes reported as fat-free mass (FFM) or lean muscle mass. During any significant weight loss — surgical, dietary, or pharmacologic — some lean mass is lost. To minimize lean mass loss on GLP-1 therapy, clinical guidance suggests 1.2-1.6 g/kg/day of dietary protein and 2-3 resistance training sessions per week. Aging adults are at higher risk of sarcopenia and may need additional monitoring.
Deep dive
Lean Mass: complete reference
Lean mass (also "lean body mass" or "fat-free mass") refers to all body tissue excluding fat — including muscle, bone, organs, fluid, and connective tissue. Skeletal muscle represents the largest component of lean mass and is the most metabolically active tissue, contributing approximately 20% of resting metabolic rate at typical body composition. Lean mass is critical для metabolic health: more lean mass = higher metabolic rate, better glycemic control, lower fall risk in aging, and better functional capacity. During weight loss, both fat and lean mass typically decline — the proportion varies dramatically based on protein intake, exercise (especially resistance training), and rate of loss. GLP-1-induced rapid weight loss is associated with ~25-40% of total weight loss coming from lean tissue without targeted intervention. Preservation strategies: adequate protein (0.7-1g per pound goal weight minimum), resistance training 2-3×/week, gradual rather than aggressive caloric deficit beyond what GLP-1 creates naturally.
- In practice
- You lose 30 lbs on Wegovy. Without protein/exercise focus, ~10 lbs may be lean mass (muscle). With protein + lifting, you can lose 25+ lbs of fat while preserving most muscle.
- Clinical context
- Lean mass preservation is the most overlooked aspect of GLP-1 weight loss. Protein + resistance training are evidence-based interventions.
Medications
Lean Mass is most directly relevant to the following GLP-1 medications:
Related terms
- Body Composition — The proportion of fat mass, lean mass (muscle), bone, and water in the body. GLP-1-induced weight lo…
Continue learning
GLP1Zoom glossary is educational reference. Definitions are summary interpretations of clinical sources and not a substitute for prescribing-information detail. Full disclaimer.
References
Glucagon-Like Peptide-1 Receptor Agonists: Mechanisms и Clinical Use (Drucker, Cell Metabolism)(2018)
Tirzepatide GIP/GLP-1 Dual Agonism: Mechanism Review (Lancet Diabetes & Endocrinology)(2021)
GLP-1 Effects on Gastric Emptying: Pharmacology Review (American J Physiology)(2020)
Endocrine Society Clinical Practice Guideline: Pharmacological Management of Obesity(2015)
STEP-1 trial: Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding et al., NEJM)(2021)
SURMOUNT-1 trial: Tirzepatide Once Weekly для Treatment of Obesity (Jastreboff et al., NEJM)(2022)
SUSTAIN-6 trial: Semaglutide and Cardiovascular Outcomes (Marso et al., NEJM)(2016)
SURPASS-2 trial: Tirzepatide vs Semaglutide в Type 2 Diabetes (Frias et al., NEJM)(2021)
LEADER trial: Liraglutide and Cardiovascular Outcomes в T2D (Marso et al., NEJM)(2016)